Dividend compounder review

ALKS

Alkermes Plc · NASDAQ · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score54.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 20.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 15.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$241.7M
Free Cash Flow$480.3M
FCF Covers DividendUnknown
Debt / Equity0.90
P/E49.2
Revenue Growth 5Y7.3%
Net Margin9.8%
ROE9.4%
Price vs Trend35.3%
3Y Return32.8%
5Y Return83.5%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

ALKS dividend review warning Warning · Warning

No usable dividend history found.